The Clinical Utility of FLT3 Mutation Testing in Acute Leukemia: A Canadian Consensus

Bergeron, J; Capo-Chichi, JM; Tsui, HB; Mahe, E; Berardi, P; Minden, MD; Brandwein, JM; Schuh, AC

Bergeron, J (通讯作者)，Univ Montreal, Inst Univ Hematol Oncol & Therapie Cellulaire, CEMTL Installat Maisonneuve Rosemont, Montreal, PQ H1T 2M4, Canada.

CURRENT ONCOLOGY, 2023; 30 (12): 10410

Abstract

FMS-like tyrosine kinase 3 (FLT3) mutations are detected in approximately 20-30% of patients with acute myeloid leukemia (AML), with the presence of a......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索